AIC
DXCM icon

Argus Investors Counsel’s DexCom DXCM Stock Holding History

Argus Investors Counsel’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
17,876
-472
-3% -$31.4K 0.93% 32
2026
Q1 		$1.15M Buy
+18,348
New +$1.28M 1.02% 28

Other funds holding DXCM

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Argus Investors Counsel's DXCM Position: Q2 2026 in Review

Argus Investors Counsel reduced its DexCom (DXCM) stake by 2.6% in Q2 2026, selling an estimated $31.4K and leaving 17,876 shares worth $1.2M. The position accounts for 0.93% of the portfolio, ranked #32.

Argus Investors Counsel first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 353 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Argus Investors Counsel held 17,876 shares of DexCom worth $1.2M as of Q2 2026.
  • Argus Investors Counsel sold 472 DexCom shares in Q2 2026, an estimated $31.4K.
  • DexCom made up 0.93% of Argus Investors Counsel's portfolio in Q2 2026, its #32 holding.
  • Argus Investors Counsel first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
  • 353 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Argus Investors Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.